Terms: = Bone cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Clinical Outcome
2 results:
1. MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway.
Gao LF; Jia S; Zhang QM; Xia YF; Li CJ; Li YH
Clin Transl Oncol; 2022 Feb; 24(2):266-275. PubMed ID: 34318428
[TBL] [Abstract] [Full Text] [Related]
2. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
Mitsui Y; Hirata H; Arichi N; Hiraki M; Yasumoto H; Chang I; Fukuhara S; Yamamura S; Shahryari V; Deng G; Saini S; Majid S; Dahiya R; Tanaka Y; Shiina H
Oncotarget; 2015 Apr; 6(11):9577-91. PubMed ID: 25797254
[TBL] [Abstract] [Full Text] [Related]
